Brian Wildermuth

Brian Wildermuth is the Senior Director of Global Oncology Marketing for ENHERTU at Daiichi Sankyo, Inc. He has a robust background in the pharmaceutical industry, particularly in oncology marketing. In his current role, he oversees the marketing strategies for ENHERTU, which is a global oncology product aimed at treating various cancers.

Professional Background

• Daiichi Sankyo, Inc.: Wildermuth has been with Daiichi Sankyo since 2021, initially serving as the NSCLC and Gastric Marketing Lead before advancing to his current position as Senior Director.13
• Novartis Oncology: Prior to joining Daiichi Sankyo, he held several key roles at Novartis, including Director of US Launch Lead and Associate Director of Hematology Marketing. He also worked as a Senior Product Manager and Product Training Manager during his tenure there.12
• GSK: Wildermuth began his career at GlaxoSmithKline (GSK), where he served as an Oncology Account Manager and Regional Sales Director, focusing on respiratory therapies.1

Education

Brian Wildermuth studied Biology, Theology, and Pre-Med at Boston College. However, specific details regarding the years of his education are not available.1

Skills and Expertise

Wildermuth is recognized for his expertise in leading global marketing campaigns and launching new pharmaceutical products. His extensive experience in oncology marketing positions him as a significant figure in the industry.1

For more information about his professional journey, you can view his LinkedIn profile under the username brian-wildermuth-4a366536.2